HEAL Initiative: Therapeutics Development for Opioid Use Disorder in Patients with Co-occurring Mental Disorders (UG3/UH3 - Clinical Trial Optional)
Closed Posted
- Opportunity number
- RFA-DA-23-049
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Categories
-
- Education
- Health
- Eligible applicants
-
- City/Township Governments
- Public or Indian Housing Auth.
- County Governments
- Other
- Tribal Organizations (Not Federally Recognized)
- Independent School Districts
- State Governments
- For Profit Organizations
- Higher Education Inst. (Public)
- Tribal Governments (Federally Recognized)
- 501(c)(3) Nonprofits
- Small Businesses
- Higher Education Inst. (Private)
- Special District Governments
- Non-501(c)(3) Nonprofits
- Full announcement
Opportunity details come from Grants.gov. Updated .
Synopsis
THE PURPOSE OF THIS FOA IS TO SUPPORT RESEARCH THAT ACCELERATES THE DISCOVERY AND DEVELOPMENT OF SAFE AND EFFECTIVE THERAPEUTICS FOR OUD IN PATIENTS WITH CO-OCCURRING COMD. THE THERAPEUTIC INTERVENTIONS MAY INCLUDE MEDICATIONS, DEVICES, OR DIGITAL THERAPEUTICS. THE GOAL IS TO SUPPORT RESEARCH THAT ADDRESSES THE URGENT NEED TO HAVE SAFE AND EFFECTIVE THERAPEUTICS FOR OUD IN PATIENTS WITH CO-OCCURRING COMD.
Files
| File | Type | Posted |
|---|---|---|
| RFA-DA-23-049-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity